<p>Endava plc（纽约证券交易所代码：DAVA - 获取免费报告）在周四的午盘交易中因令人失望的财报公告而创下 52 周新低。该公司股价最低跌至 14.50 美元，最后交易价为 15.60 美元，成交量为 6931065 股。该股票此前收盘价为 21.41 美元。</p>
<ul>
<li>Globant 是一个新兴的人工智能投资机会，正在扩大其市场份额</li>
</ul>
<p>该公司报告本季度每股收益（EPS）为 0.32 美元，低于分析师一致预期的 0.38 美元，差距为 0.06 美元。Endava 的净利润率为 0.74%，股本回报率为 0.89%。</p>
<h2>华尔街分析师预测增长</h2>
<p>多位分析师对该公司发表了评论。Guggenheim 将 Endava 的目标价从 40.00 美元下调至 28.00 美元，并在周二的研究报告中给予该公司 “买入” 评级。摩根士丹利将 Endava 的目标价从 33.00 美元上调至 35.00 美元，并在 1 月 31 日的研究报告中给予该股票 “持平” 评级。Susquehanna 将 Endava 的目标价从 55.00 美元下调至 50.00 美元，并在 2 月 21 日的研究报告中给予该公司 “积极” 评级。最后，Needham &amp; Company LLC 将 Endava 的目标价从 43.00 美元下调至 38.00 美元，并在 2 月 21 日的研究报告中给予该公司 “买入” 评级。四位投资分析师对该股票给予持有评级，六位分析师给予该公司股票买入评级。根据 MarketBeat.com 的数据，Endava 目前的平均评级为 “适度买入”，共识目标价为 37.31 美元。</p>
<ul>
<li>Endava 在超出第四季度共识预期后股价上涨</li>
</ul>
<p><strong>查看我们对 Endava 的最新分析</strong></p>
<h2>机构投资者对 Endava 的看法</h2>
<p>大型投资者最近买入和卖出了该股票的股份。Quantbot Technologies LP 在第一季度收购了 Endava 的新股份，价值 25000 美元。Assetmark Inc.在第四季度将其在 Endava 的股份增加了 93.1%。Assetmark Inc.现在拥有 985 股该公司的股票，价值 30000 美元，此前在该期间又购买了 475 股。Blue Trust Inc.在第四季度将其在 Endava 的股份增加了 28.5%。Blue Trust Inc.现在拥有 1494 股该公司的股票，价值 46000 美元，此前在该期间又购买了 331 股。Quadrant Capital Group LLC 在第四季度将其在 Endava 的股份增加了 114.2%。Quadrant Capital Group LLC 现在拥有 1474 股该公司的股票，价值 46000 美元，此前在该期间又购买了 786 股。最后，Smartleaf Asset Management LLC 在第一季度将其在 Endava 的股份增加了 23.5%。Smartleaf Asset Management LLC 现在拥有 3620 股该公司的股票，价值 72000 美元，此前在该期间又购买了 689 股。机构投资者和对冲基金持有该公司 62.23% 的股份。</p>
<h2>Endava 价格表现</h2>
<p>该公司的 50 日移动平均价格为 19.26 美元，200 日移动平均价格为 25.85 美元。该公司的债务与股本比率为 0.21，流动比率为 1.90，速动比率为 1.90。该公司的市值为 9.2088 亿美元，市盈率为 141.82，市盈增长比率为 2.26，贝塔值为 1.25。</p>
<h2>关于 Endava</h2>
<p>（获取免费报告）</p>
<p>Endava plc 为北美、欧洲、英国及国际客户提供消费品、医疗保健、移动和零售领域的技术服务。它在支付和金融服务、电信、媒体和技术领域提供创意和生产服务；并提供业务分析、数据分析、项目管理、数字产品战略、私募股权价值提升、IT 战略、架构、扩展现实、机器学习和人工智能、产品设计以及用户体验和视觉设计服务。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Endava 更好</li>
<li>内部交易可能并不会告诉你你想的那样</li>
<li>SMCI 股票反弹：两天内上涨 45% 可能只是开始</li>
<li>便士股票是否适合你的投资组合？</li>
<li>AMD 的人工智能驱动股票价格反弹刚刚换挡</li>
<li>顶尖生物科技股票：探索创新机会</li>
<li>5 只小型股内部人士在关税恐慌高峰时买入</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Endava 吗？</h2>
<p>在你考虑 Endava 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在就买入，以便在更广泛的市场注意到之前……而 Endava 并不在名单上。</p>
<p>虽然 Endava 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得买入。</p>
<p>在这里查看这五只股票</p>

DAVA

<p>Endava plc（纽约证券交易所代码：DAVA）在报告每股收益为 0.32 美元，低于预期的 0.38 美元后，股价创下 52 周新低 14.50 美元。该股最后交易于 15.60 美元，较前一交易日收盘价 21.41 美元下跌。分析师们已调整了他们的目标价，古根海姆将其下调至 28.00 美元，而摩根士丹利则将其上调至 35.00 美元。机构投资者持有该公司 62.23% 的股份，该公司的市值为 9.2088 亿美元，市盈率为 141.82</p>

<p>Endava plc (NYSE:DAVA - Get Free Report) shares hit a new 52-week low during mid-day trading on Thursday following a dissappointing earnings announcement. The company traded as low as $14.50 and last traded at $15.60, with a volume of 6931065 shares traded. The stock had previously closed at $21.41.</p>
<div class="lb-trans"><p>Endava plc（纽约证券交易所代码：DAVA - 获取免费报告）在周四的午盘交易中因令人失望的财报公告而创下 52 周新低。该公司股价最低跌至 14.50 美元，最后交易价为 15.60 美元，成交量为 6931065 股。该股票此前收盘价为 21.41 美元。</p>
</div><ul>
<li>Globant Is an Emerging AI Play That’s Expanding Its Footprint</li>
</ul>
<div class="lb-trans"><ul>
<li>Globant 是一个新兴的人工智能投资机会，正在扩大其市场份额</li>
</ul>
</div><p>The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.38 by ($0.06). Endava had a net margin of 0.74% and a return on equity of 0.89%.</p>
<div class="lb-trans"><p>该公司报告本季度每股收益（EPS）为 0.32 美元，低于分析师一致预期的 0.38 美元，差距为 0.06 美元。Endava 的净利润率为 0.74%，股本回报率为 0.89%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several analysts have commented on the company. Guggenheim reduced their price objective on Endava from $40.00 to $28.00 and set a &#34;buy&#34; rating for the company in a research note on Tuesday. Morgan Stanley increased their target price on Endava from $33.00 to $35.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Friday, January 31st. Susquehanna cut their target price on Endava from $55.00 to $50.00 and set a &#34;positive&#34; rating for the company in a research note on Friday, February 21st. Finally, Needham &amp; Company LLC cut their target price on Endava from $43.00 to $38.00 and set a &#34;buy&#34; rating for the company in a research note on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, Endava presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $37.31.</p>
<div class="lb-trans"><p>多位分析师对该公司发表了评论。Guggenheim 将 Endava 的目标价从 40.00 美元下调至 28.00 美元，并在周二的研究报告中给予该公司 “买入” 评级。摩根士丹利将 Endava 的目标价从 33.00 美元上调至 35.00 美元，并在 1 月 31 日的研究报告中给予该股票 “持平” 评级。Susquehanna 将 Endava 的目标价从 55.00 美元下调至 50.00 美元，并在 2 月 21 日的研究报告中给予该公司 “积极” 评级。最后，Needham &amp; Company LLC 将 Endava 的目标价从 43.00 美元下调至 38.00 美元，并在 2 月 21 日的研究报告中给予该公司 “买入” 评级。四位投资分析师对该股票给予持有评级，六位分析师给予该公司股票买入评级。根据 MarketBeat.com 的数据，Endava 目前的平均评级为 “适度买入”，共识目标价为 37.31 美元。</p>
</div><ul>
<li>Endava Trading Higher After Topping Q4 Consensus Views</li>
</ul>
<div class="lb-trans"><ul>
<li>Endava 在超出第四季度共识预期后股价上涨</li>
</ul>
</div><p><strong>View Our Latest Analysis on Endava</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Endava 的最新分析</strong></p>
</div><h2>Institutional Investors Weigh In On Endava</h2>
<div class="lb-trans"><h2>机构投资者对 Endava 的看法</h2>
</div><p>Large investors have recently bought and sold shares of the stock. Quantbot Technologies LP acquired a new stake in Endava during the 1st quarter valued at $25,000. Assetmark Inc. grew its stake in Endava by 93.1% during the fourth quarter. Assetmark Inc. now owns 985 shares of the company's stock worth $30,000 after buying an additional 475 shares during the period. Blue Trust Inc. boosted its position in shares of Endava by 28.5% in the fourth quarter. Blue Trust Inc. now owns 1,494 shares of the company's stock worth $46,000 after buying an additional 331 shares during the period. Quadrant Capital Group LLC boosted its position in shares of Endava by 114.2% in the fourth quarter. Quadrant Capital Group LLC now owns 1,474 shares of the company's stock worth $46,000 after buying an additional 786 shares during the period. Finally, Smartleaf Asset Management LLC boosted its position in shares of Endava by 23.5% in the first quarter. Smartleaf Asset Management LLC now owns 3,620 shares of the company's stock worth $72,000 after buying an additional 689 shares during the period. Institutional investors and hedge funds own 62.23% of the company's stock.</p>
<div class="lb-trans"><p>大型投资者最近买入和卖出了该股票的股份。Quantbot Technologies LP 在第一季度收购了 Endava 的新股份，价值 25000 美元。Assetmark Inc.在第四季度将其在 Endava 的股份增加了 93.1%。Assetmark Inc.现在拥有 985 股该公司的股票，价值 30000 美元，此前在该期间又购买了 475 股。Blue Trust Inc.在第四季度将其在 Endava 的股份增加了 28.5%。Blue Trust Inc.现在拥有 1494 股该公司的股票，价值 46000 美元，此前在该期间又购买了 331 股。Quadrant Capital Group LLC 在第四季度将其在 Endava 的股份增加了 114.2%。Quadrant Capital Group LLC 现在拥有 1474 股该公司的股票，价值 46000 美元，此前在该期间又购买了 786 股。最后，Smartleaf Asset Management LLC 在第一季度将其在 Endava 的股份增加了 23.5%。Smartleaf Asset Management LLC 现在拥有 3620 股该公司的股票，价值 72000 美元，此前在该期间又购买了 689 股。机构投资者和对冲基金持有该公司 62.23% 的股份。</p>
</div><h2>Endava Price Performance</h2>
<div class="lb-trans"><h2>Endava 价格表现</h2>
</div><p>The company has a 50-day moving average price of $19.26 and a two-hundred day moving average price of $25.85. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.90 and a quick ratio of 1.90. The company has a market cap of $920.88 million, a PE ratio of 141.82, a P/E/G ratio of 2.26 and a beta of 1.25.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均价格为 19.26 美元，200 日移动平均价格为 25.85 美元。该公司的债务与股本比率为 0.21，流动比率为 1.90，速动比率为 1.90。该公司的市值为 9.2088 亿美元，市盈率为 141.82，市盈增长比率为 2.26，贝塔值为 1.25。</p>
</div><h2>About Endava</h2>
<div class="lb-trans"><h2>关于 Endava</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.</p>
<div class="lb-trans"><p>Endava plc 为北美、欧洲、英国及国际客户提供消费品、医疗保健、移动和零售领域的技术服务。它在支付和金融服务、电信、媒体和技术领域提供创意和生产服务；并提供业务分析、数据分析、项目管理、数字产品战略、私募股权价值提升、IT 战略、架构、扩展现实、机器学习和人工智能、产品设计以及用户体验和视觉设计服务。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Endava</li>
<li>Insider Trades May Not Tell You What You Think</li>
<li>SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start</li>
<li>Are Penny Stocks a Good Fit for Your Portfolio?</li>
<li>AMD’s AI-Powered Stock Price Rally Just Shifted Gears</li>
<li>Top Biotech Stocks: Exploring Innovation Opportunities</li>
<li>5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Endava 更好</li>
<li>内部交易可能并不会告诉你你想的那样</li>
<li>SMCI 股票反弹：两天内上涨 45% 可能只是开始</li>
<li>便士股票是否适合你的投资组合？</li>
<li>AMD 的人工智能驱动股票价格反弹刚刚换挡</li>
<li>顶尖生物科技股票：探索创新机会</li>
<li>5 只小型股内部人士在关税恐慌高峰时买入</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Endava Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Endava 吗？</h2>
</div><p>Before you consider Endava, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Endava 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在就买入，以便在更广泛的市场注意到之前……而 Endava 并不在名单上。</p>
</div><p>While Endava currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Endava 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得买入。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Endava（NYSE:DAVA）在收益未达预期后创下 1 年新低